Related Experiment Video
Updated: Jan 30, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
Two roads for oncolytic immunotherapy development
Howard L Kaufman1,2, Praveen K Bommareddy3
1Division of Surgical Oncology, Massachusetts General Hospital, 55 Fruit Street, Warren 401, Boston, MA, 02114, USA. HLKaufman@mgh.harvard.edu.
Abstract:
Oncolytic viruses are an emerging class of immunotherapy agents for cancer treatment. In this issue of JITC, Machiels et al. reports early phase data from an oncolytic adenovirus given by intravenous (IV) administration. While this may allow easy access to metastatic lesions, there is limited data supporting the therapeutic effectiveness of this approach. Further studies should include assessment of viral replication in tumor tissue and consider comparative trials using IV and intratumoral delivery to fully optimize oncolytic immunotherapy.
Insights
Early phase trials show an oncolytic adenovirus administered intravenously may offer cancer immunotherapy. Further research is needed to confirm its effectiveness and optimize delivery methods for oncolytic virotherapy.
Area of Science:
- Oncology
- Virology
- Immunotherapy
Background:
- Oncolytic viruses represent a promising new frontier in cancer immunotherapy.
- Intravenous (IV) administration of oncolytic agents is being explored for broader tumor access.
Purpose of the Study:
- To report early phase clinical data on an oncolytic adenovirus administered via IV infusion.
- To evaluate the potential of IV oncolytic adenovirus for cancer treatment.
Main Methods:
- Early phase clinical trial data analysis.
- Intravenous administration of an oncolytic adenovirus.
Main Results:
- The study presents initial findings on the intravenous administration of an oncolytic adenovirus.
- Limited data currently exists to fully support the therapeutic efficacy of this IV approach.
Conclusions:
- Intravenous oncolytic adenovirus administration is a potential route for cancer immunotherapy, particularly for metastatic lesions.
- Further investigations are crucial, including assessing viral replication in tumors and comparing IV with intratumoral delivery to optimize oncolytic immunotherapy strategies.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Design Example: Alignment of a Road Line Using GIS
Sustainable Development
Development of the Lymphatic System
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
Language Development
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

